[{"notes_id":"1_836","category":"12","subcategory":"0","title":"COPD: stable management","body":"NICE updated its guidelines on the management of chronic obstructive pulmonary disease (COPD) in 2018.<br \/><br \/>General management<br \/><ul><li><span class=\"concept\" data-cid=\"4006\">>smoking cessation<\/span> advice: including offering nicotine replacement therapy, varenicline or bupropion<\/li><li>annual influenza vaccination<\/li><li>one-off pneumococcal vaccination<\/li><li><span class=\"concept\" data-cid=\"3990\">pulmonary rehabilitation<\/span> to all people who view themselves as functionally disabled by COPD (usually Medical Research Council [MRC] grade 3 and above)<\/li><\/ul><br \/>Bronchodilator therapy<br \/><ul><li><span class=\"concept\" data-cid=\"1499\">a short-acting beta2-agonist (SABA) or short-acting muscarinic antagonist (SAMA) is first-line treatment<\/span><\/li><li>for patients who remain breathless or have exacerbations despite using short-acting bronchodilators the next step is determined by whether the patient has <i>'asthmatic features\/features suggesting steroid responsiveness'<\/i><\/li><\/ul><br \/>There are a <span class=\"concept\" data-cid=\"9525\">number of criteria NICE suggest to determine whether a patient has asthmatic\/steroid responsive features:<\/span><br \/><ul><li>any previous, secure diagnosis of asthma or of atopy<\/li><li>a higher blood eosinophil count - note that NICE recommend a full blood count for all patients as part of the work-up<\/li><li>substantial variation in FEV1 over time (at least 400 ml)<\/li><li>substantial diurnal variation in peak expiratory flow (at least 20%)<\/li><\/ul><br \/>Interestingly NICE do not recommend formal reversibility testing as one of the criteria. In the guidelines they state that <i>'routine spirometric reversibility testing is not necessary as part of the diagnostic process or to plan initial therapy with bronchodilators or corticosteroids. It may be unhelpful or misleading...'<\/i>. They then go on to discuss why they have reached this conclusion. Please see the guidelines for more details.<br \/><br \/>No asthmatic features\/features suggesting steroid responsiveness<br \/><ul><li><span class=\"concept\" data-cid=\"889\">add a long-acting beta2-agonist (LABA) + long-acting muscarinic antagonist (LAMA)<\/span><ul><li><span class=\"concept\" data-cid=\"7723\">if already taking a SAMA, discontinue and switch to a SABA<\/span><\/li><\/ul><\/li><\/ul><br \/>Asthmatic features\/features suggesting steroid responsiveness<br \/><ul><li><span class=\"concept\" data-cid=\"890\">LABA + inhaled corticosteroid (ICS)<\/span><\/li><li>if patients remain breathless or have exacerbations offer <span class=\"concept\" data-cid=\"7505\">triple therapy i.e. LAMA + LABA + ICS<\/span><ul><li><span class=\"concept\" data-cid=\"7723\">if already taking a SAMA, discontinue and switch to a SABA<\/span><\/li><\/ul><\/li><li>NICE recommend the use of combined inhalers where possible<\/li><li>NICE specifically mention the <span class=\"concept\" data-cid=\"12493\">risk of pneumonia<\/span> in patients with COPD using inhaled corticosteroids<\/li><\/ul><br \/><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd542b.png\" data-fancybox=\"gallery\" data-caption=\"NICE 2018 COPD guidelines - simplified flowchart\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd542.png\" alt=\"\" \/><\/a><\/div><\/div><\/div><br \/>Oral theophylline<br \/><ul><li>NICE only recommends theophylline after trials of short and long-acting bronchodilators or to people who cannot used inhaled therapy<\/li><li>the dose should be reduced if macrolide or fluoroquinolone antibiotics are co-prescribed<\/li><\/ul><br \/>Oral prophylactic antibiotic therapy<br \/><ul><li><span class=\"concept\" data-cid=\"9761\">azithromycin prophylaxis is recommended in select patients<\/span><\/li><li>patients <span class=\"concept\" data-cid=\"10638\">should not smoke<\/span>, have optimised standard treatments and continue to have exacerbations<\/li><li>other prerequisites include a CT thorax (to exclude bronchiectasis) and sputum culture (to exclude atypical infections and tuberculosis)<\/li><li>LFTs and an <span class=\"concept\" data-cid=\"9526\">ECG to exclude QT prolongation should also be done as azithromycin can prolong the QT interval<\/span><\/li><\/ul><br \/><span class=\"concept\" data-cid=\"12253\">Standby medication: NICE recommend offering a short course of oral corticosteroids and oral antibiotics<\/span> to keep at home if:  <a href='https:\/\/www.nice.org.uk\/guidance\/ng115\/chapter\/Recommendations#managing-stable-copd:~:text=Offer%20people%20a%20short%20course%20of%20oral%20corticosteroids%20and%20a%20short%20course%20of%20oral%20antibiotics%20to%20keep%20at%20home%20as%20part%20of%20their%20exacerbation%20action%20plan%20if%3A' title='NICE - 2018 COPD guidelines' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE<\/a> <br \/><ul><li>have had an exacerbation within the last year<\/li><li>understand how to take the medication, and are aware of associated risks and benefits<\/li><li>know to when to seek help and when to ask for replacements once medication has been used<\/li><\/ul><br \/>Mucolytics<br \/><ul><li>should be 'considered' in patients with a chronic productive cough and continued if symptoms improve<\/li><\/ul><br \/><span class=\"concept\" data-cid=\"12077\">Phosphodiesterase-4 (PDE-4) inhibitors<\/span>  <a href='https:\/\/www.nice.org.uk\/guidance\/ta461\/chapter\/1-Recommendations#:~:text=1-,Recommendations,-1.1' title='NICE - Roflumilast NICE recommendations' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE<\/a> <br \/><ul><li>oral PDE-4 inhibitors such as roflumilast reduce the risk of COPD exacerbations in patients with severe COPD and a history of frequent COPD exacerbations<\/li><li>NICE recommend if:<ul><li>the disease is severe, defined as a forced expiratory volume in 1 second (FEV1) after a bronchodilator of less than 50% of predicted normal, and<\/li><li>the person has had 2 or more exacerbations in the previous 12 months despite triple inhaled therapy with a long-acting muscarinic antagonist, a long-acting beta-2 agonist and an inhaled corticosteroid<\/li><\/ul><\/li><\/ul><br \/>Cor pulmonale<br \/><ul><li>features include peripheral oedema, raised jugular venous pressure, systolic parasternal heave, loud P2<\/li><li>use a loop diuretic for oedema, consider long-term oxygen therapy<\/li><li>ACE-inhibitors, calcium channel blockers and alpha blockers are not recommended by NICE<\/li><\/ul><br \/>Factors which may improve survival in patients with stable COPD<br \/><ul><li>smoking cessation - the single most important intervention in patients who are still smoking <\/li><li>long term oxygen therapy in patients who fit criteria <\/li><li>lung volume reduction surgery in selected patients<\/li><\/ul>","notes_hash":"1b3e15be8109654eb018de2330833108","knowledge_graph_node_id_link":0,"links":"<table style='width:100%'><tr><td>Global Initiative for Chronic Obstructive Lung Disease<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_40\" data-linkid=\"40\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_40\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">25<\/span><button type=\"button\" style=\"\" id=\"link_dislike_40\" data-linkid=\"40\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_40\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">39<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/goldcopd.org\/\">GOLD criteria 2017<\/a><\/td><\/tr><\/table><br><br><table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1362\" data-linkid=\"1362\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1362\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">19<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1362\" data-linkid=\"1362\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1362\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">21<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/TA461\/chapter\/1-Recommendations\">Roflumilast NICE recommendations<\/a><\/td><\/tr><\/table><br><br><table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1202\" data-linkid=\"1202\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1202\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">35<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1202\" data-linkid=\"1202\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1202\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">33<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng115\/chapter\/Recommendations\">2018 COPD guidelines<\/a><\/td><\/tr><\/table><br><br><table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1429\" data-linkid=\"1429\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1429\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">50<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1429\" data-linkid=\"1429\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1429\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">16<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng115\/resources\/visual-summary-treatment-algorithm-pdf-6604261741\">2018 COPD management diagram<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/f\/f3\/Chronic_bronchitis.webm\" data-description=\"Chronic bronchitis\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"984\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/css\/images\/osmosis.png\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/f\/f3\/Chronic_bronchitis.webm\" data-description=\"Chronic bronchitis\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"984\">Chronic bronchitis<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1710\" data-mediaid=\"1710\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1710\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1710\" data-mediaid=\"1710\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1710\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/GGkajjvMEAQ\" data-description=\"Cor pulmonale\" data-upvotes=\"8\" data-downvotes=\"3\" data-media=\"1291\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/GGkajjvMEAQ\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/GGkajjvMEAQ\" data-description=\"Cor pulmonale\" data-upvotes=\"8\" data-downvotes=\"3\" data-media=\"1291\">Cor pulmonale<\/a><\/td><\/tr><tr><td><span ><small>Zero To Finals - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2286\" data-mediaid=\"2286\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2286\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">8<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2286\" data-mediaid=\"2286\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2286\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/UQGRcg35Dmk\" data-description=\"Cor pulmonale\" data-upvotes=\"7\" data-downvotes=\"3\" data-media=\"897\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/UQGRcg35Dmk\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/UQGRcg35Dmk\" data-description=\"Cor pulmonale\" data-upvotes=\"7\" data-downvotes=\"3\" data-media=\"897\">Cor pulmonale<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1562\" data-mediaid=\"1562\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1562\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1562\" data-mediaid=\"1562\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1562\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/XBg6hxGgyS4\" data-description=\"Understanding COPD\" data-upvotes=\"2\" data-downvotes=\"4\" data-media=\"1468\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/XBg6hxGgyS4\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/XBg6hxGgyS4\" data-description=\"Understanding COPD\" data-upvotes=\"2\" data-downvotes=\"4\" data-media=\"1468\">Understanding COPD<\/a><\/td><\/tr><tr><td><span ><small>Armando Hasudungan - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2588\" data-mediaid=\"2588\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2588\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2588\" data-mediaid=\"2588\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2588\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"889":{"concept_text":"COPD - still breathless despite using SABA\/SAMA and <b>no<\/b> asthma\/steroid responsive features --> add a LABA + LAMA","concept_percentile":"70"},"890":{"concept_text":"COPD - still breathless despite using SABA\/SAMA and <b>asthma\/steroid responsive features<\/b> --> add a LABA + ICS","concept_percentile":"50"},"1499":{"concept_text":"A SABA or SAMA is the first-line pharmacological treatment of COPD","concept_percentile":"94"},"7505":{"concept_text":"COPD - still breathless despite using SABA\/SAMA and a LABA + ICS --> add a LAMA","concept_percentile":"60"},"9525":{"concept_text":"Asthmatic features\/features suggesting steroid responsiveness in COPD: \r\n   - previous diagnosis of asthma or atopy\r\n   - a higher blood eosinophil count\r\n   - substantial variation in FEV1 over time (at least 400 ml)\r\n   - substantial diurnal variation in peak expiratory flow (at least 20%)","concept_percentile":"79"},"9761":{"concept_text":"Azithromycin prophylaxis is recommended in COPD patients who meet certain criteria and who continue to have exacerbations","concept_percentile":"87"},"12253":{"concept_text":"COPD standby medication: NICE recommend offering a short course of oral corticosteroids and oral antibiotics to keep at home","concept_percentile":"98"}},"category_name":"Respiratory","subcategory_name":"","comment_count":19},"",[]]